Novartis AG DIO Ratio 2011-2026 | NVS

Annual DIO Ratio Novartis AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	130	131	128	135	131	114

All numbers in USD currency

Maximum	Minimum	Average
135	114	128

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Xeris Pharmaceuticals XERS	501	$ 6.03	-1.55 %	$ 885 M	USA
UroGen Pharma Ltd. URGN	377	$ 19.2	-11.52 %	$ 554 M	Israel
uniQure N.V. QURE	19.4 K	$ 10.89	-30.36 %	$ 530 M	Niderland
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
Agenus AGEN	0.163	$ 3.36	0.86 %	$ 1.2 M	USA
Agios Pharmaceuticals AGIO	1.74 K	$ 29.16	-3.54 %	$ 1.69 B	USA
Завод ДИОД DIOD	768	-	-	-	Russia
Фармсинтез LIFE	120	-	-	-	Russia
Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
Teligent, Inc. TLGT	198	-	-13.85 %	$ 16.1 M	USA
Amarin Corporation plc AMRN	292	$ 13.98	1.27 %	$ 5.7 B	Irlanda
AbbVie ABBV	91.6	$ 233.57	0.64 %	$ 413 B	USA
Blueprint Medicines Corporation BPMC	315	-	-	$ 8.14 B	USA
AIM ImmunoTech AIM	303	$ 0.8	-11.6 %	$ 38.5 M	USA
Aptorum Group Limited APM	4.89	$ 0.83	5.37 %	$ 4.53 M	China